Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;82(6):e221.
doi: 10.1016/j.jaad.2020.04.017. Epub 2020 Apr 10.

Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?

Affiliations

Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?

Angela Patrì et al. J Am Acad Dermatol. 2020 Jun.
No abstract available

PubMed Disclaimer

Comment in

References

    1. Zhou D., Dai S.M., Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020:dkaa114. - PMC - PubMed
    1. Yao X., Ye F., Zhang M., et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis. 2020:ciaa237. - PMC - PubMed
    1. Lv C., Liu W., Wang B., et al. Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo. Antiviral Res. 2018;159:55–62. - PubMed
    1. Caly L., Druce J.D., Catton M.G., Jans D.A., Wagstaff K.M. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 doi: 10.1016/j.antiviral.2020.104787. - DOI - PMC - PubMed
    1. Sanz-Navarro J., Feal C., Dauden E. Treatment of human scabies with oral ivermectin. eczematous eruptions as a new non-reported adverse event. Actas Dermosifiliogr. 2017;108(7):643–649. - PubMed